Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05378763
Title A Study of Poziotinib in Previously Treated Participants With Locally Advanced or Metastatic NSCLC Harboring HER2 Exon 20 Mutations (PINNACLE)
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Spectrum Pharmaceuticals, Inc
Indications

lung non-small cell carcinoma

Therapies

Poziotinib

Docetaxel

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST